Quest Enlists Paige’s AI Expertise To Develop Software For Digitized Cancer Diagnosis
Quest signed an agreement with Paige to develop regulatory-approved software and services to be marketed to expand digital pathology network for pathologists.
You may also be interested in...
In this week’s podcast, Medtech Insight's UK-based reporter Barnaby Pickering provides an update on Medtronic’s MiniMed 780G insulin pump cost-savings study, presented at the Advances Technologies & Treatments for Diabetes (ATTD) conference. US Commercial and R&D manager, Reed Miller, highlights details on CVRx’s recent IPO.
Medtronic Announces FDA Approval Of SenSight Directional Lead System For Treating Movement Disorders
Medtronic said it will launch the SenSight DBS in the US after winning FDA approval. The total DBS market is expected to exceed $1bn by 2024, according to Meddevicetracker.
Roche’s Foundation Medicine still leads Guardant Health in terms of total companion-diagnostic US FDA approvals as both companies announced new PMA supplements.